Hydration Pharmaceuticals Company Ltd has released a press release.
Q2 FY22 Quarterly Activities Report (App 4C)
Filed with ASX ·
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
Story so far
Earlier from Hydration Pharmaceuticals
- Issue of Securities
- Record monthly sales in June
- Application for quotation of securities - HPC
- Q1 FY22 Quarterly Activities Report (App 4C)
- Hydralyte North America grows sales 122% on PCP
Later from Hydration Pharmaceuticals
- Appendix 4D and FY22 Half Year Financial Report
- FY22 Half Year Results Announcement
- $12m Loan Facility Secured to Capitalise on Recent Growth
- Q3 FY22 Quarterly Activities Report (App 4C)
- First tranche draw-down of secured loan facility completed
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals